NCT06904677View on ClinicalTrials.gov

Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2029

Conditions

Colorectal Cancer (CRC)Neoadjuvant TherapyProteomics

Trial Locations (1)

100021

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER